Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Integra Therapeutics

Explore full profile

Integra Therapeutics is a biotech company developing next-generation gene writing tools to cure genetic diseases

Barcelona, SpainFounded 2020Biotech & Life Sciences
Valuation $50–100M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Integra Therapeutics and the history behind them.

About Integra Therapeutics

Integra-TX is a technology startup that operates in the digital communications sector. The company's primary service involves the provision of technical storage and access solutions. These solutions are designed to facilitate the use of specific services requested by subscribers or users, and to enable the transmission of communication across electronic communication networks.

Integra-TX's services are essential for businesses that rely on digital communication and data storage. The company's solutions are designed to store user preferences, which are not explicitly requested by the subscriber or user. This feature is particularly useful for businesses that want to enhance their customer service by understanding and anticipating their customers' needs and preferences.

Moreover, Integra-TX also offers services that are used exclusively for statistical purposes. This means that the company provides tools that allow businesses to collect and analyze data about their operations and customers. This data can be used to make informed decisions and improve business performance.

One of the unique features of Integra-TX's services is the emphasis on user privacy. The company ensures that the information stored or retrieved cannot be used to identify the user without additional records from a third party or voluntary compliance from the internet service provider.

Finally, Integra-TX also offers services that are used to create user profiles for advertising purposes and to track users across different websites for similar marketing purposes. This means that the company provides tools that allow businesses to target their marketing efforts more effectively.

In terms of its business model, Integra-TX makes money by charging its clients for the use of its technical storage and access solutions.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Barcelona, Spain
Employees
23
Open positions
None listed
Dealroom signal
75.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Gene Therapy, Spinout, EIC, Biotech and Pharma, EIC Fund, EIT Health, Woman Founder, EIT Ecosystem
Business model
Manufacturing
Client focus
b2b

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Sep 2025 $12M $47M AdBio partners · Invivo Partners · CDTI Innvierte · Takeda Ventures ↗
SUPPORT PROGRAM✓Other financing Jan 2025 $0 — EIT Health —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthProfitMargin
2026
2025
2024
2023 —
2022 — — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Integra Therapeutics website traffic

Latest recorded traffic for Integra Therapeutics is 1.1K monthly website visits, down 57.7% over the last three months. Integra Therapeutics's team declined 4.2% over the past year.

Latest monthly visits1.1K 3-month web change-57.7% 1-year team growth-4.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

  • AdBio partners
  • Takeda
  • Invivo Partners
  • Columbus Venture Partners
  • European Innovation Council
  • CDTI Innvierte
  • Takeda Ventures

Series A1 investor entered at this stage

  • EIC Fund

Other known investors2 additional known investors

  • EIT Health
  • Pompeu Fabra University
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇪🇸 Spain79.2%
🇳🇱 Netherlands8.3%
🇺🇸 United States8.3%
🇨🇴 Colombia4.2%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Integra Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Integra Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.